We are live on ! Find out more
COCH icon

Envoy Medical
COCH

93 hedge funds and large institutions have $368M invested in Envoy Medical in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

2% more capital invested

Capital invested by funds: $362M → $368M (+$6.67M)

7% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 15

1% less funds holding

Funds holding: 94 → 93 (-1)

1.13% less ownership

Funds ownership: 87.31% → 86.18% (-1.1%)

Holders
93
Holders Change
-1
Holders Change %
-1.06%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
14
Increased
20
Reduced
13
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
KIM
Karpus Investment Management
New York
+$9.02M
2
Jane Street
Jane Street
New York
+$5.21M
3
CIM
Cowen Investment Management
New York
+$3.48M
4
Calamos Advisors
Calamos Advisors
Illinois
+$2.98M
5
RCM
Rivernorth Capital Management
Florida
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$34M
2
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$8.37M
3
UOC
UBS O'Connor
Illinois
-$4.2M
4
HCM
Highbridge Capital Management
New York
-$2.95M
5
CF
Cantor Fitzgerald
New York
-$2.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
51
Centiva Capital
New York
$1.72M – – –
SCM
52
Segantii Capital Management
Hong Kong
$1.51M – – –
TCM
53
Tenor Capital Management
New York
$1.5M – – –
CM
54
Cohanzick Management
New York
$1.47M -$686 -69 -0%
EC
55
Elequin Capital
New York
$1.42M +$1.39M +140,215 +9,348%
CH
56
CVI Holdings
Delaware
$1.3M -$247K -24,798 -16%
RL
57
RPO LLC
Connecticut
$1.28M +$1.27M +127,500 New
BFM
58
Boothbay Fund Management
New York
$1.17M +$418K +42,075 +56%
AC
59
Athos Capital
Hong Kong
$1.01M – – –
RA
60
RiverPark Advisors
New York
$997K – – –
MTIM
61
Marathon Trading Investment Management
Pennsylvania
$997K – – –
MTCM
62
Mint Tower Capital Management
Netherlands
$958K +$951K +95,586 New
AC
63
Ayrton Capital
Connecticut
$831K – – –
CCM
64
CAAS Capital Management
New York
$713K – – –
Bank of Nova Scotia
65
Bank of Nova Scotia
Ontario, Canada
$707K – – –
AA
66
Ancora Advisors
Ohio
$645K -$87.5K -8,800 -12%
LCM
67
Lynwood Capital Management
Ontario, Canada
$636K – – –
Susquehanna International Group
68
Susquehanna International Group
Pennsylvania
$621K – – –
SIM
69
Sandia Investment Management
Massachusetts
$607K -$1.1K -111 -0.2%
PI
70
PEAK6 Investments
Illinois
$565K – – –
CAC
71
Cowen and Company
New York
$532K +$528K +53,054 New
COPPSERS
72
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$501K – – –
HHGC
73
Hunting Hill Global Capital
New York
$501K – – –
OCAM
74
Owl Creek Asset Management
New York
$501K – – –
HF
75
HRT Financial
New York
$481K -$36.2K -3,639 -7%
1 2
3
4 5

COCH Hedge Fund Activity: Q4 2022 in Review

93 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2022, worth a combined $368M — up 1.8% from $362M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of COCH and 14 opened new positions — a net loss of 1 holder — while 13 trimmed existing stakes and 20 added.

The largest buyer was Karpus Investment Management, adding an estimated $9.02M. The largest seller was Glazer Capital LLC, cutting an estimated $34M.

  • 93 institutional investors held Envoy Medical (COCH) as of Q4 2022, down from 94 in Q3 2022.
  • Funds reported $368M of Envoy Medical stock for Q4 2022, up 1.8% quarter-over-quarter.
  • 14 funds opened new Envoy Medical positions in Q4 2022 and 15 closed out, a net change of -1 holder.
  • The largest Envoy Medical buyer in Q4 2022 was Karpus Investment Management, an estimated $9.02M added.
  • The largest Envoy Medical seller in Q4 2022 was Glazer Capital LLC, an estimated $34M sold.

Based on aggregated 13F filings for Q4 2022.